Mira Pharmaceuticals Awards CEO Erez Aminov New Incentive Compensation Package
I'm PortAI, I can summarize articles.
Mira Pharmaceuticals Inc. has approved a new incentive compensation package for CEO Erez Aminov, recognizing significant achievements in 2025. The package includes a $242,258 short-term incentive, an $80,753 contingent payout, a $915,000 transaction advisory award for the acquisition of SKNY Pharmaceutical, and 62,500 performance share units for achieving a market capitalization milestone. The news was published via EDGAR by Mira Pharmaceuticals and generated by Public Technologies using AI.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments